Hikma Pharmaceuticals is a pharmaceutical company that develops, manufactures and markets generic and branded medicines. Its products include injectable medicines, oral tablets and capsules, and other prescription treatments supplied to hospitals, clinics and pharmacies. The company operates manufacturing sites and sales operations across the Middle East and North Africa, the United States and Europe, and it is headquartered in London. It serves healthcare providers and patients through a portfolio of generic and licensed medicines.
On this site Hikma Pharmaceuticals PLC appears as a stock on the London Exchange (UK), code HIK, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #979 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
78/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average12.4%
From 52-week high-6.0%
MomentumFair
65/100
Typical recent returns for this exchange.
See the numbers →
3-month return7.1%
6-month return27.1%
12-month, skipping last month-5.5%
Stability (higher is calmer)Weak
44/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)35.8%
Worst drawdown, 1 year (smaller is calmer)-35.2%
LiquidityStrong
97/100
Trades actively.
See the numbers →
Avg daily value traded1,186.65M GBX
Zero-volume days0.0%
IncomeWeak
30/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.0%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 1,134.72 – 1,782.86Daily closes, split-adjusted
Signals
50-day average1,608.54
200-day average1,469.58
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)42.12
Technical summary
Daily
Strongly bullish
12 bullish · 3 neutral · 1 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
1,630.3
Bullish
EMA 10
1,633.2
Bullish
SMA 20
1,614.1
Bullish
EMA 20
1,619.5
Bullish
SMA 50
1,608.5
Bullish
EMA 50
1,598.1
Bullish
SMA 100
1,560.5
Bullish
EMA 100
1,561.6
Bullish
SMA 200
1,469.6
Bullish
EMA 200
1,542.2
Bullish
Oscillators (daily)
RSI (14)
57.40
Neutral
MACD (12, 26)
14.85
Bullish
Momentum (12)
4.56
Bullish
Stochastic %K (14)
77.24
Neutral
Williams %R (14)
-22.76
Neutral
CCI (20)
142.1
Bearish
Pivot points (classic, last session)
S3
1,579.7
S2
1,605.3
S1
1,628.7
Pivot
1,654.3
R1
1,677.7
R2
1,703.3
R3
1,726.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.64 GBP
Yield on today's price
0.04%
Frequency
Semi-annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
13 Aug 2026
0.2909
19 Mar 2026
0.3529
14 Aug 2025
0.2701
20 Mar 2025
0.3721
15 Aug 2024
0.2427
21 Mar 2024
0.3714
10 Aug 2023
0.1988
23 Mar 2023
0.2952
18 Aug 2022
0.1600
17 Mar 2022
0.2600
19 Aug 2021
0.1300
18 Mar 2021
0.2470
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
